Development and characterization of liposomal doxorubicin hydrochloride with palm oil

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Sabeti, Bahareh ^a   Noordin, Mohamed Ibrahim ^a   Mohd, Shaharuddin ^b   Hashim, Rosnani ^b   Dahlan, Afendi ^b   Akbari Javar, Hamid ^c  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b CYBERJAYA UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (Malaysia)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; PALM OIL; PHOSPHATIDYLCHOLINE; ANTINEOPLASTIC ANTIBIOTIC; LIPOSOME; MACROGOL DERIVATIVE; VEGETABLE OIL;

ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG TARGETING; DRUG UPTAKE; EX VIVO STUDY; FREEZE THAWING; HUMAN; HUMAN CELL; PARTICLE SIZE; PH; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ANALOGS AND DERIVATIVES; APOPTOSIS; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; DOXORUBICIN; HUMANS; LIPOSOMES; PARTICLE SIZE; PLANT OILS; POLYETHYLENE GLYCOLS;

EID: 84899564918     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/765426     Document Type: Article

References (32)

1. Tacar O.; Sriamornsak P.; Dass C. R.; Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. Journal of Pharmacy and Pharmacology 2013 65 2 157 170
2. Gabizon A. A.; Lyass O.; Berry G. J.; Wildgust M.; Cardiac safety of pegylated liposomal doxorubicin (Doxil/Caelyx) demonstrated by endomyocardial biopsy in patients with advanced malignancies. Cancer Investigation 2004 22 5 663 669 2-s2.0-10044262383 10.1081/CNV-200032899 (Pubitemid 40064725)
3. Gabizon A. A.; Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Research 1992 52 4 891 896 2-s2.0-0026603586
4. Gabizon A.; Goren D.; Horowitz A. T.; Tzemach D.; Lossos A.; Siegal T.; Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals. Advanced Drug Delivery Reviews 1997 24 2-3 337 344 2-s2.0-0343923453 10.1016/S0169-409X(96)00476-0 (Pubitemid 27112652)
5. Torchilin V. P.; Recent advances with liposomes as pharmaceutical carriers. Nature Reviews Drug Discovery 2005 4 2 145 160 2-s2.0-14144250911 10.1038/nrd1632 (Pubitemid 40282557)
6. Edem D. O.; Palm oil: biochemical, physiological, nutritional, hematological, and toxicological aspects: a review. Plant Foods for Human Nutrition 2002 57 3-4 319 341 2-s2.0-0036770253 10.1023/A:1021828132707 (Pubitemid 36189079)
7. Elson C. E.; Qureshi A. A.; Coupling the cholesterol- and tumor-suppressive actions of palm oil to the impact of its minor constituents on 3-hydroxy-3-methylglutaryl coenzyme a reductase activity. Prostaglandins Leukotrienes and Essential Fatty Acids 1995 52 2-3 205 208 2-s2.0-0028861784 10.1016/0952-3278(95)90024-1
8. Kamat J. P.; Devasagayam T. P. A.; Tocotrienols from palm oil as potent inhibitors of lipid peroxidation and protein oxidation in rat brain mitochondria. Neuroscience Letters 1995 195 3 179 182 2-s2.0-0029144077 10.1016/0304-3940(95)11812-B
9. Mozafari M. R.; Liposomes: an overview of manufacturing techniques. Cellular and Molecular Biology Letters 2005 10 4 711 719 2-s2.0-31544446865 (Pubitemid 43161695)
10. Riaz M.; Liposomes preparation methods. Pakistan Journal of Pharmaceutical Sciences 1996 19 1 65 77
11. Mayer L. D.; Tai L. C. L.; Bally M. B.; Mitilenes G. N.; Ginsberg R. S.; Cullis P. R.; Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. Biochimica et Biophysica Acta 1990 1025 2 143 151 2-s2.0-0025346245 10.1016/0005-2736(90)90091-2 (Pubitemid 20199621)
12. Gregoriadis G.; Entrapment of drugs and other materials into liposomes. Liposome Technology 2007 2 3rd Informa HealthCare
13. Niu G.; Cogburn B.; Hughes J.; Preparation and characterization of doxorubicin liposomes. Cancer Nanotechnology 2010 Springer 211 219
14. Traïkia M.; Warschawski D. E.; Recouvreur M.; Cartaud J.; Devaux P. F.; Formation of unilamellar vesicles by repetitive freeze-thaw cycles: characterization by electron microscopy and 31P-nuclear magnetic resonance. European Biophysics Journal 2000 29 3 184 195 2-s2.0-0033835604 10.1007/s002490000077
15. Mu X.; Zhong Z.; Preparation and properties of poly(vinyl alcohol)-stabilized liposomes. International Journal of Pharmaceutics 2006 318 1-2 55 61 2-s2.0-33745494878 10.1016/j.ijpharm.2006.03.016 (Pubitemid 43963300)
16. Almgren M.; Edwards K.; Karlsson G.; Cryo transmission electron microscopy of liposomes and related structures. Colloids and Surfaces A 2000 174 1-2 3 21 2-s2.0-0034670221 10.1016/S0927-7757(00)00516-1 (Pubitemid 30628959)
17. Gupta P. N.; Mishra V.; Rawat A.; Dubey P.; Mahor S.; Jain S.; Chatterji D. P.; Vyas S. P.; Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. International Journal of Pharmaceutics 2005 293 1-2 73 82 2-s2.0-15044349794 10.1016/j.ijpharm.2004.12.022 (Pubitemid 40381082)
18. Heldt N.; Gauger M.; Zhao J.; Slack G.; Pietryka J.; Li Y.; Characterization of a polymer-stabilized liposome system. Reactive and Functional Polymers 2001 48 1 181 191 2-s2.0-0035795566 10.1016/S1381-5148(01) 00055-4 (Pubitemid 32541821)
19. Fogli S.; Danesi R.; Innocenti F.; Di Paolo A.; Bocci G.; Barbara C.; Del Tacca M.; An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma. Therapeutic Drug Monitoring 1999 21 3 367 375 2-s2.0-0032967418 10.1097/00007691-199906000-00022 (Pubitemid 29249535)
20. Pereira-Lachataignerais J.; Pons R.; Panizza P.; Courbin L.; Rouch J.; López O.; Study and formation of vesicle systems with low polydispersity index by ultrasound method. Chemistry and Physics of Lipids 2006 140 1-2 88 97 2-s2.0-33645839863 10.1016/j.chemphyslip.2006.01.008
21. Mazuel C.; Grove J.; Gerin G.; Keenan K. P.; HPLC-MS/MS determination of a peptide conjugate prodrug of doxorubicin, and its active metabolites, leucine-doxorubicin and doxorubicin, in dog and rat plasma. Journal of Pharmaceutical and Biomedical Analysis 2003 33 5 1093 1102 2-s2.0-0345490736 10.1016/S0731-7085(03)00434-5 (Pubitemid 37501012)
22. Panwar P.; Pandey B.; Lakhera P. C.; Singh K. P.; Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes. International Journal of Nanomedicine 2010 5 1 101 108 2-s2.0-77951183192
23. Saarinen-Savolainen P.; Järvinen T.; Taipale H.; Urtti A.; Method for evaluating drug release from liposomes in sink conditions. International Journal of Pharmaceutics 1997 159 1 27 33 2-s2.0-0344222162 10.1016/S0378- 5173(97)00264-0 (Pubitemid 28062807)
24. Sznitowska M.; Stokrocka M.; Determination of diclofenac released from suppositories using UV spectrophotometry, spectra derivative spectrophotometry and HPLC. Acta Poloniae Pharmaceutica 2007 64 5 401 405 2-s2.0-40549090921 (Pubitemid 351360393)
25. Iwasa A.; Akita H.; Khalil I.; Kogure K.; Futaki S.; Harashima H.; Cellular uptake and subsequent intracellular trafficking of R8-liposomes introduced at low temperature. Biochimica et Biophysica Acta 2006 1758 6 713 720 2-s2.0-33746084052 10.1016/j.bbamem.2006.04.015 (Pubitemid 44080073)
26. Miglietta A.; Cavalli R.; Bocca C.; Gabriel L.; Rosa Gasco M.; Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel. International Journal of Pharmaceutics 2000 210 1-2 61 67 2-s2.0-0034605981 10.1016/S0378-5173(00)00562-7 (Pubitemid 32332642)
27. Hu F.-Q.; Wu X.-L.; Du Y.-Z.; You J.; Yuan H.; Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin. European Journal of Pharmaceutics and Biopharmaceutics 2008 69 1 117 125 2-s2.0-41549087356 10.1016/j.ejpb.2007.09.018 (Pubitemid 351467161)
28. Park S.; Yoo H. S.; In vivo and in vitro anti-cancer activities and enhanced cellular uptakes of EGF fragment decorated doxorubicin nano-aggregates. International Journal of Pharmaceutics 2010 383 1-2 178 185 2-s2.0-70449522992 10.1016/j.ijpharm.2009.08.039
29. Yuan H.; Miao J.; Du Y.-Z.; You J.; Hu F.-Q.; Zeng S.; Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. International Journal of Pharmaceutics 2008 348 1-2 137 145 2-s2.0-37249078585 10.1016/j.ijpharm.2007.07.012 (Pubitemid 350266242)
30. Nastruzzi C.; Lipospheres in Drug Targets and Delivery: Approaches, Methods, and Applications 2004 CRC Press
31. Cheng M.; Gao X.; Wang Y.; Synthesis of glycyrrhetinic acid-modified chitosan 5-fluorouracil nanoparticles and its inhibition of liver cancer characteristics in vitro and in vivo. Marine Drugs 2013 11 9 3517 3536 10.3390/md11093517
32. Gilbert R. G.; Hess M.; Jenkins A. D.; Jones R. G.; Kratochvíl P.; Stepto R. F. T.; Dispersity in polymer science. Pure and Applied Chemistry 2009 81 2 351 353 2-s2.0-61449111871 10.1351/PAC-REC-08-05-02